VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1486165
Sex: F
Age:
State: FL

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Chills; headache; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 31Mar2021 at 14:45(at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, genetic asymptomatic carrier for familial mediterranean fever and iodine allergy. In the year 2019 the patient received yellow fever vaccine, measles, mumps, rubella vaccine and hepatitis A and B vaccine and experienced very strong reactions including a golf-ball sized ball in her arm on the 3rd hepatitis A and hepatitis B dose that required steroids to bring it down. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm left on 10Mar2021 at 07:15 for COVID-19 immunisation. After the first dose of the vaccination, on 10Mar2021, after three hours, at 10:15, the patient experienced chills and on the next day, 11Mar2021, the patient experienced a hangover-type headache. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. For the second dose, the hangover-type headache started on the same day as the shot, 31Mar2021 and experienced sporadic chills on day 2. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatments for the event. The clinical outcome of the events chills and headache were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486166
Sex: F
Age:
State: NJ

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Tiredness; Poor sleep; Arm Pain; Swelling; Sore throat; Dizziness; Chills; Muscle aches/pains; Nausea; Night sweats; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the right arm on 29Mar2021 at 14:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to COVID vaccine. Concomitant medications included vitamin c (NATURES BOUNTY) and HUM pre and probiotics (MANUFACTURER UNKOWN) started on an unknown date for unspecified indication. On 29Mar2021 at 16:00, the patient experienced tiredness, poor sleep, arm pain, swelling, sore throat, dizziness, chills, muscle aches or pains, nausea and night sweats but no fever. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events tiredness, poor sleep, arm pain, swelling, sore throat, dizziness, chills, muscle aches or pains, nausea and night sweats was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Vitamin c

Current Illness:

ID: 1486167
Sex: F
Age:
State: CA

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Fever; Chills; Cough; Lung irritation; Nasal congestion; Aches; This is a spontaneous report from a contactable other health care professional, the patient. A 32-year-old non-pregnant female patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Unknown) via unspecified route of administration in the right arm on 30Mar2021, at 13:15 as a single dose for COVID-19 immunisation (at the age of 32-years-old). Medical history included neck injury and allergy to sulfa antibiotics. Concomitant medications included sertraline hydrochloride (ZOLOFT), tramadol (MANUFACTURER UNKNOWN), carisoprodol (SOMA), paracetamol (TYLENOL), ibuprofen (MOTRIN), and magnesium (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was diagnosed with COVID-19 in Dec2020, on unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 31Mar2021, at 16:00 the patient experienced fever, aches, chills, cough, lung irritation, and nasal congestion. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient had not received treatment for events. The clinical outcome of events fever, aches, chills, cough, lung irritation, and nasal congestion was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ZOLOFT; TRAMADOL; Soma; TYLENOL; Motrin; MAGNESIUM

Current Illness:

ID: 1486168
Sex: F
Age:
State: PA

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Hives all over the face; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 12:00 PM (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included shellfish allergy, allergy to nuts, chicken allergy, shrimps and tuna fish allergy. Concomitant medication included isotretinoin (CLARAVIS) for unknown indication and from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 08:00 AM, the patient experienced hives all over the face. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event hives all over the face. The clinical outcome of the event hives all over the face was recovered on 01April 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: CLARAVIS

Current Illness:

ID: 1486169
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 03/22/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Redness between the toes affecting the lower half of toes. The toes feel very warm.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on an unknown date (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin, nickel, histamine in food and persimmon. The patient was allergic to neomycin. Concomitant medications included bifidobacterium longum, lactobacillus acidophilus, lactobacillus rhamnosus (PROBIOTICS), magnesium aspartate (MAGNESIUM), calcium carbonate, vitamin d nos (CALCIUM WITH VIT D) and dexpanthenol, nicotinamide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride (B-COMP) used for unknown indication from an unspecified date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 27Feb2021 at 15:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021 at 18:00, the patient experienced redness between the toes affecting the lower half of toes. The toes felt very warm. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit or urgent care. The clinical outcome of the event redness was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROBIOTICS; MAGNESIUM; Calcium with vit D; B-comp

Current Illness:

ID: 1486170
Sex: M
Age:
State: FL

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Sleeplessness; exhausted; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm left on 09Mar2021 at 11:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea and allergy to walnuts. Concomitant medications included unspecified anaesthetic (MANUFACURER UNKNOWN) started on an unknown date for root canal procedure at dentist and ibuprofen (IBUPROFEN) started on an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Mar2021 at 04:00, the patient experienced sleeplessness. The patient had been unable to sleep for more than a few hours at a time. At first, the patient thought it was psychological (excitement/ anxiety) but this had persisted for weeks and it was unprecedented since the first shot. The patient also reported that he was usually exhausted by mid afternoon or early evening and often took a nap. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 30Mar2021 at 09:45 (at the age of 54-year-old), as a single dose for COVID-19 immunisation. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events sleeplessness and exhausted was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN

Current Illness: Allergy to nuts (walnut allergy)

ID: 1486171
Sex: F
Age:
State: KS

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Injection site soreness; arm soreness; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8733), via an unspecified route of administration in the left arm on 30Mar2021 at 15:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies to medications, food, or other products. Concomitant medications included calcium carbonate, magnesium carbonate, magnesium trisilicate (TUMS) for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 16:00, the patient experienced injection site soreness, arm soreness and tiredness. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of injection site soreness, arm soreness and tiredness were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Tums

Current Illness:

ID: 1486172
Sex: F
Age:
State: WA

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Vertigo; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 43-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 23Mar2021 at 13:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation Medical history included possible Grave's Disease, untreated. Concomitant medications included amoxicillin and clavulanic acid (AUGMENTIN); levocabastine hydrochloride (ZYRTEC); MEGARED and Hibiscus Flower (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown start date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 23Mar2021 at 13:45, 30 minutes after vaccination, the patient experienced vertigo and vomiting. No therapeutic measures were taken for the adverse events. The clinical outcome of the events vertigo and vomiting was recovered on an unknown date at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Augmentin; Zyrtec

Current Illness:

ID: 1486173
Sex: F
Age:
State: VA

Vax Date:
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:around 200; Test Name: pulse rate; Result Unstructured Data: Test Result:112-115; Test Name: pulse rate; Result Unstructured Data: Test Result:78-80; Comments: Normal

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: my blood pressure when up to around 200.; My pulse rate was 112-115 but today I am back to normal; had a funky feeling; my heart starting racing; hardly got any sleep; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: ER8737) via an unspecified route of administration (age at vaccination 74-year) in Left Arm on an unspecified date as dose 2, single for COVID-19 immunization. The time was 10:45 for the second dose, as reported. Medical history included, drug hypersensitivity (penicillin allergy), drug eruption from an unknown date and unknown if ongoing. Patient's relevant Family Medical History included She states none everyone either has heart disease. Her father has heart disease and type 2 diabetes. Her mother had major heart attack and died, was brought back to life 4 times, then lived another 6 years. There were no concomitant medications. The patient previously took COVID-19 vaccine on 10Mar2021 14:30 in the afternoon, Percocet [oxycodone hydrochloride; Paracetamol] and experienced drug hypersensitivity (allergic to Percocet). No prior Vaccinations (within 4 weeks) was reported. On 31Mar2021 the patient experienced her heart starting racing, she hardly got any sleep; her blood pressure when up to around 200, her pulse rate was 112-115 but she was back to normal, she had a funky feeling on an unspecified date. It was reported that patient took the second dose of the Pfizer vaccine yesterday morning about 10:45. she didn't have to go to lengthy monitoring because they did that the first time. Last night about 7:00 and my heart starting racing and my blood pressure when up to around 200. It lasted about 2 hours and then come back down. She don't take any medications. Is that the only episode that might happen. She was severely allergic to Penicillin but it took 6 hours for her to react to the Penicillin. Her pulse rate was 112-115 but today back to normal at around 78-80. She is calling about the COVID Pfizer vaccine. She says she had her second shot yesterday morning, did not appear to have any issues, then about 7 o'clock last night her heart was racing off the charts. She states she is 74 but does not take any medication for blood pressure or anything, she is very healthy, she thought it was imperative to tell us this event since she feels it was due to the vaccine. She says she has allergies to other medications, a severe penicillin allergy. She is allergic to Percocet; she breaks out in hives. Flonase after 2 or 3 days it increases her eye pressure, she can't use any nasal spray for allergies as it affects her eye pressure. She states she was expecting a reaction, her reactions to things usually take hours to show, before they set in. She says her daughter has multiple sclerosis, she knows how important study groups are. She says her daughter has multiple sclerosis, she knows how important study groups are. She knows this vaccine has not gone through a tremendous amount of testing prior to. She says she is feeling fine today and asks is that the only time she will experience that. She says it was a scary thing last night, for 35 to 40 minutes she considered calling the emergency, she monitored it, she has a blood pressure machine and a pulse machine on her phone. She was monitoring pulse rate, for 35 minutes it was around 115 or more then finally after 35 minutes went back down, levelling off, it started back down into the range where she knew it was still up but it was getting better, this morning she is back into her 70's range. She says in the morning she had her vaccine at 10:45, they monitored her, she had no reaction to the first dose, they monitored her for 15 minutes. Then last night about 7pm in her lounge chair, she was watching tv when all of the sudden she had a funky feeling, her heart was racing she could feel the fast beating. She says she feels fine now, she hardly got any sleep since she was afraid to go to sleep, for 35 minutes it ran into 112, 113 and her range is normally about 74. Her heart rate stayed 112 to 115 for about 35 minutes. She says then it stayed in mid 90's range for a while, when she went to bed its was in the upper 80's range but it was definitely levelling off. She says it has been 24 hours from the shot, she seems fine now, she checks every half an hour, and her heart rate is in the 70's. States the outcome is unknown since it is only been 24 hours since the vaccine and she does not know if she will feel her heart racing again. States she feels like she is ok. She says no for when she was very small. When asked about AEs for any other times she states not that she can remember, the smallpox vaccine she had to take twice, the 2nd one was before she was 14, she has scars that are pretty big, she does not take a lot of meds in her life, the first time she realized about her penicillin allergies, she was in her 50's. Patient underwent lab test and procedure included Blood pressure and pulse rate. The clinical outcome of heart starting racing was recovered on 31Mar2021, her pulse rate was 112-115 but today she back to normal; was recovered on an unspecified date, while the outcome of other events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1486174
Sex: F
Age:
State: CA

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: still feel a bit weak; had a pretty strong response to it, was completely out yesterday,; headaches; This is a spontaneous report from a contactable consumer. An adult female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 31Mar2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. It was unknown if the patient had any allergies to food, medications, or other products. It was unknown if the patient was pregnant at the time of vaccination. It was unknown if the patient was diagnosed with COVID-19 prior to the vaccination. It was unknown if the patient had been tested for COVID-19 since the vaccination. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient got the second vaccine and had a pretty strong response to it and was completely out. The patient still felt a bit weak, but the headaches were gone. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if the patient received any treatment for the events had a pretty strong response to it, was completely out yesterday, felt a bit weak and headaches. The clinical outcome of the event headaches was resolved on an unknown date in 2021 while that of had a pretty strong response to it, was completely out yesterday and felt a bit weak was unknown at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486175
Sex: F
Age:
State: CA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: feeling weak; headache; Arm pain; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the arm left on 30Mar2021 at 13:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included single functional kidney. The patient had known allergies to epinephrine and lobster. The patient did not receive any other medications within two weeks of the COVD-19 vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm left on 09Mar2021 at 13:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 30Mar2021, Tuesday, at 22:00, the patient experienced pain in his arm. On 31Mar2021, Wednesday ,the patient experienced feeling weak, which got worse as the day progressed. The patient developed headache. The patient felt weak and had headache all day, and started feeling better at night. The patient felt a bit weak the next day but everything else seemed to be fine. Therapeutic measures for headache included treatment with Tylenol which was ineffective. The clinical outcome of the events pain in arm, feeling weak and headache was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486176
Sex: F
Age:
State: NJ

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: unusual headache; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 28Feb2021 at 13:15 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included papillary thyroid cancer. Concomitant medications included levothyroxine sodium (SYNTHROID) for unknown indication from an unknown date received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medication, food, or other products. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccination. On 28Feb2021 at 18:30, the patient experienced unusual headache started about 5-6 hours post injection and low-grade ache that came from the middle of the head and made her to reach in and rub it. Headache was not there for about 24 hours on 6Mar2021. No therapeutic measures were taken as a result of the event. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event headache was recovered on 10Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1486177
Sex: F
Age:
State: NJ

Vax Date: 02/15/2021
Onset Date: 02/19/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Swollen lymph nodes under left arm; swollen left breast; redness on breast; This is a spontaneous report from a contactable consumer, the patient. An 82-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201) via an unspecified route of administration in the left arm on 15Feb2021 (at the age of 82-years-old), as a single dose for COVID-19 immunisation. Medical history included allergic to wasp bites. Concomitant medications received within two weeks of vaccination included statin (MANUFACTURER UNKNOWN), for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL8982) via an unspecified route of administration in the left arm on 25Jan2021 at 00:00 (at the age of 82-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Feb2021, the patient experienced swollen lymph nodes under left arm, swollen left breast and also redness on breast. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swollen lymph nodes under left arm, swollen left breast and redness on breast was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486178
Sex: M
Age:
State: CA

Vax Date: 03/10/2021
Onset Date: 03/18/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Ringing in my ears. Tinnitus.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6203) via an unspecified route of administration in the left arm on 10Mar2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included immunization. Concomitant medications were not reported. The patient previously received vaccine flu shot (MANUFACTURER UNKNOWN) in the left arm on 18Feb2021 for immunisation. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021, the patient experienced ringing in ears, tinnitus which did not stop or go away. Therapeutic measures were taken as a result of reported event was unknown. The adverse events resulted in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event ringing in ears, tinnitus was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486179
Sex: M
Age:
State: NY

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 33-years-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734), via an unspecified route of administration in the left arm on 31Mar2021 at 12:15 (at the age of 33-years old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 31Mar2021 at 23:00, the patient experienced full body muscle spasms. It was reported that the episode lasted for thirty minutes, stopped briefly then started again for a couple hours and it felt like a shiver from the cold but then it never stops and 100x worse. It was reported that he was exhausted after the spasm event. The patient did not receive any treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of full body muscle spasms and exhausted was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486180
Sex: F
Age:
State: AZ

Vax Date: 03/03/2021
Onset Date: 03/17/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210308; Test Name: COVID-19; Test Result: Negative ; Comments: COVID test type- other

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: balding; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 03Mar2021 at 19:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 27Mar2021 at 15:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient had medical history that was unspecified and has known allergies. The patient received other medications within 2 weeks of vaccination that were unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination the patient had been tested for COVID-19. The patient had undergone COVID-19 test on 08Mar2021, and was tested negative. On 17Mar2021, may be 2 weeks after the first COVID-19 vaccine, the patient noticed when combing her hair, that she started to see a comb full of hair instead of few strands, and hair in the top was gone as patient was balding. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event balding was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486181
Sex: F
Age:
State: OK

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: congestion; cough; eyes hurt; nasal drip; aches and pains all over; fever; chills; fatigue; headache; This is a spontaneous report from a contactable consumer, the patient. A 72-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 31Mar2021 at 10:15 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included acute frontal sinusitis, thyroid disorder (underactive thyroid), type 2 diabetes mellitus without complication, mixed hyperlipidemia, blood pressure high, COVID-19, seafood allergy, fish allergy, and drug allergy (all statins drug allergy). Patient received other medications in two weeks which included ipratropium (MANUFACTURER UNKNOWN) and fluticasone propionate (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication received within 2 weeks of vaccination. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6207) via an unspecified route of administration in the arm left on 10Mar2021 at 12:45 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 19:00 the patient experienced fever, chills, cough, fatigue, congestion, headache, eyes hurt, nasal drip, aches and pains all over. Patient received treatment for the events which included cephalexin antibiotic for sinuses, tylen. The reported events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of fever, chills, cough, fatigue, nasal congestion, headache, pain in eyes, post nasal drip, general body pain was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected

Other Meds: IPRATROPIUM; FLUTICASONE PROPIONATE

Current Illness:

ID: 1486182
Sex: F
Age:
State: OR

Vax Date: 03/28/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Tachycardia heartbeat; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 28Mar2021 at 11:15 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. Medical history included epilepsy, blood pressure high and fruit allergy (avocados). Concomitant medications included benazepril (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN), valproate semi sodium (DEPAKOTE) and carbamazepine (CARBAMA), all taken for an unknown indication, since unspecified dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 16:00, the patient experienced tachycardia heartbeat. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the tachycardia heartbeat. The clinical outcome of the event tachycardia was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: BENAZEPRIL; HYDROCHLOROTHIAZIDE; DEPAKOTE; CARBAMA

Current Illness:

ID: 1486183
Sex: F
Age:
State: OH

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the right arm on 27Mar2021 at 11:30 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. Medical history included thyroid disorder. The patient had no known allergies. Concomitant medications included penicillin (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and estradiol (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Mar2021 at 09:00, the patient experienced severe headaches and nausea. On 01Apr2021, 5 days after the vaccination, the patient experienced hives on left lower leg. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the severe headaches, nausea and hives were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; ESTRADIOL

Current Illness:

ID: 1486184
Sex: F
Age:
State: PA

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Headache; This is a spontaneous report from a contactable consumer, the parent. A 20-year-old non-pregnant female patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021(at the age of 20-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient received concomitant medication included unspecified birth control within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced headache. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event headache was recovered on 01Apr2021 at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486185
Sex: M
Age:
State: VA

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Swelling in right knee; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 25Mar2021 at 11:30 as a single dose (at the age of 43-years-old) for COVID-19 immunisation. The medical history of the patient was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 10:00, the patient experienced swelling in right knee. The patient did not receive any treatment for the reported event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swelling in right knee was recovering at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486186
Sex: F
Age:
State: CA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202104; Test Name: Body temperature; Result Unstructured Data: Test Result:101 degree; Comments: 101 degree fever currently; Test Date: 20210330; Test Name: Body temperature; Result Unstructured Data: Test Result:102-4 degree; Comments: at 20:00 Ran a 102-4 degree fever for approximately 36 hours

Allergies:

Symptom List: Unevaluable event

Symptoms: Ran a 102-4 degree fever for approximately 36 hours, followed by a 101 degree fever currently.; I have large painful lumps in both armpits (golf ball size).; I have large painful lumps in both armpits (golf ball size).; I have had full bodyaches,; joint pain; chills during fevers, especially at night.; I have a very prominent metallic taste in my mouth.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 10:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hypothyroidism and depression. Concomitant medications included bupropion hydrochloride 160 (WELLBUTRIN), levothyroxine .50 (MANUFACTURER UNKNOWN)) and fluticasone propionate; salmeterol xinafoate 250 (ADVAIR); all taken from an unspecified date for an unknown indication. The patient was allergic to latex, kiwi, avocado, banana, pineapple and mango. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 09Mar2021 at 12:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 20:00, the patient experienced 102 - 4 degree fever for approximately 36 hours, followed by a 101 degree fever currently. The patient had large painful lumps in both armpits (golf ball size); also had full body aches, joint pain, and chills during fevers, especially at night. The patient had very prominent metallic taste in my mouth. The event did not result in doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events fever, swelling, armpit pain, general body pain, joint pain, fever chills and taste metallic were not resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: WELLBUTRIN; LEVOTHYROXINE; ADVAIR

Current Illness:

ID: 1486187
Sex: M
Age:
State: WI

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Nasal Swab; Test Result: Negative ; Comments: covid_test_type_post_vaccination=Nasal Swab; Test Date: 20201008; Test Name: Nasal Swab; Test Result: Positive ; Comments: covid_test_type_post_vaccination=Nasal Swab

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Fatigue,; very bad chills after 24 hours after first dose; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er8764) via an unspecified route of administration on 31Mar2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 01Apr2021 (reported as 31Mar2021) (after 24 hours of first dose), the patient experienced fatigue and very bad chills. It was unknown if the patient received any treatment for the reported event. On 08Oct2020, the patient had nasal swab for COVID-19 test and resulted positive. On an unknown date, the patient had nasal swab and resulted negative (reported as thrice). The clinical outcome of events fatigue and very bad chills were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486188
Sex: M
Age:
State: GA

Vax Date: 03/28/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Night/sleep sweats; Fever; headache; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm (also reported as left shoulder) on 28Mar2021 at 15:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to food, medications, or other products. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 09:00, within 48 hours of the vaccine, the patient experienced fever that went away on 31Mar2021 (reported as next day). The patient also experienced night/sleep sweats and headache within the 48 hours which were still present. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events fever, night/sleep sweats and headache. The clinical outcome of the event fever was resolved on 31Mar2021 while that of night/sleep sweats and headache was not resolved at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486189
Sex: F
Age:
State: NE

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Blisters on tongue; Yeast infection symptoms; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 13:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. The patient had allergy to sartans. Concomitant medication included insulin aspart (NOVOLOG) since an unknown date for unknown indication. The patient previously took rabies vaccine inact (chick embryo) (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced allergy to vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 31Mar2021 at 21:00, the patient experienced blisters on tongue. About 8 to 9 hours after vaccination, the patient got yeast infection symptoms. The patient did not receive any treatment for the events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events blisters on tongue and yeast infection symptoms were unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: NOVOLOG

Current Illness:

ID: 1486190
Sex: F
Age:
State: CT

Vax Date: 03/26/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: rash at injection site (raised, circular red rash); This is a spontaneous report from a contactable consumer, the patient. A 30-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP-6955), via an unspecified route of administration in the left arm on 26Mar2021 at 12:00, (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Medical history included anxiety, treenuts allergy, shellfish allergy and melons allergy. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and ethinylestradiol, norethisterone (ALYACEN); both for unspecified indication from unknown dates. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and CECLOR; both for unspecified indication and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL-3247), via an unspecified route of administration in the left arm on an unspecified date in Mar2021 at 12:00 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 22:00, the patient experienced rash at injection site (raised, circular red rash). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event vaccination site erythema was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: SERTRALINE; ALYACEN

Current Illness:

ID: 1486191
Sex: F
Age:
State: AZ

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: BMI; Result Unstructured Data: Test Result:49 (Unspecified units); Test Date: 20210327; Test Name: Heart rate; Result Unstructured Data: Test Result:Heart was slightly elevated for my normal rates

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Severe diarrhea for three days; Nausea; Fatigue; Heart was slightly elevated; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 27Mar2021 at 13:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included gallbladder removal and obesity (BMI 49). The patient had no allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, at 14:30, the patient experienced severe diarrhea, nausea, fatigue and heart was slightly elevated. The patient reported that she had severe diarrhea for three days following vaccination date along with other side effects like nausea, fatigue and her heart was slightly elevated than normal rates. She stated that, she was reporting this in hope of bringing awareness for others without gall bladders and high BMI. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events severe diarrhea, nausea, fatigue and heart was slightly elevated was recovered/resolved with sequelae on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486192
Sex: M
Age:
State: MI

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: fatigue; extreme pain in lower extremities; headache; general feeling of being unwell; This is a spontaneous report from a contactable pharmacist. A 65-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Mar2021(at the age of 65-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications. The patient did not had allergy to any medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021, at 23:00 the patient began to experience fatigue, extreme pain in lower extremities, headache, and general feeling of being unwell. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events fatigue, extreme pain in lower extremities, headache, and general feeling of being unwell were recovered on an unknown date. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486193
Sex: F
Age:
State: NY

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210326; Test Name: High Fever; Result Unstructured Data: Test Result:103 (Unspecified unit)

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: body aches (back, head, shoulders, neck, stiff neck, etc); chills; high fever 103; fatigue/wiped out; no strength; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG6207) via an unspecified route of administration in the left arm on 25Mar2021 at 18:30 (at the age of 54-year-old), as a single dose for COVID-19 immunisation. Medical history included breast cancer, 10 years prior in 2011. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG6201) via an unspecified route of administration in the left arm on 04Mar2021 at 20:30 (at the age of 53-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26March2021, day after shot, the patient experienced chills, high fever 103, fatigue, no strength, and wiped out. On 27Mar2021, the patient experienced body aches (back, head, shoulders, neck, stiff neck, etc), and fatigue. On 26Mar2021, the body temperature was reported as 103. Therapeutic measures were taken as a result of the event fever and included treatment with TYLENOL, fever broke approximately at 18:00 after taking TYLENOL a few hours earlier on 27Mar2021. The clinical outcome of the events chills, high fever, fatigue, no strength, wiped out, and body aches (back, head, shoulders, neck, stiff neck, etc) was recovered on unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486194
Sex: F
Age:
State: MI

Vax Date: 03/11/2021
Onset Date: 03/23/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Metallic taste in my mouth; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 10:30 am (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism (Just Thyroid (Hypo) - had been taking medication close to 20 years). The patient did not have allergies to medications, food, or other products. Concomitant medications included levothyroxine sodium (SYNTHROID) of 0.025 mg daily and omeprazole (MANUFACTURER UNKNOWN) 20 - daily OTC on an unknown date for unspecified indication. The patient also previously received the first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: EM9810) via an unspecified route of administration in the left arm on 11Feb2021 at 10:30 am (at the age of 51-years-old) as a single dose for Covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, the patient experienced metallic taste. The patient reported that she woke up with metallic taste in her mouth that did not go away. She did not have infection in her mouth, and it also could be from sinus drainage, but she never had this type of taste in her mouth. The patient did not receive any treatment for the reported adverse event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event metallic taste was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; OMEPRAZOLE

Current Illness:

ID: 1486195
Sex: M
Age:
State: CT

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Abdominal pain; Cramp; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955), via an unspecified route of administration in the left arm on 31Mar2021 at 10:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included pollen allergy. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3247), via an unspecified route of administration in the left arm on 10Mar2021 at 10:30 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 10:00, after 24 hours of vaccination, the patient experienced abdominal pain and cramp for 3 hours. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the abdominal pain and cramp was resolved on 01Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: Vitamin d

Current Illness:

ID: 1486196
Sex: F
Age:
State: MA

Vax Date: 03/28/2021
Onset Date: 03/28/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 19-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 28Mar2021 at 11:30 (at the age of 19-years-old) as a single dose for COVID-19 immunization. Medical history included hormonal implant inserted in Feb2019 and birth control. The patient did not have any allergies to medications, food, or other products. Concomitant medications included etonogestrel (NEXPLANON) for birth control from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021, within 12 hours of receiving the vaccine, the patient started to have period and it had not varied greatly in flow and cramps. No therapeutic measures were taken as a result of adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events irregular periods and menstrual cramps was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: NEXPLANON

Current Illness:

ID: 1486197
Sex: M
Age:
State: SC

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Swollen lymph nodes under armpit of injection; dull headache; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: ek873c), via an unspecified route of administration in the left arm on 30Mar2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and high cholesterol. The patient did not have any allergies to medications, food, or other products. The patient did not receive any medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: ENGZ06), via an unspecified route of administration in the left arm on 09Mar2021 at 10:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 15:00, +30hrs after second shot, the patient experienced swollen lymph nodes under armpit of injection site and dull headache. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events swollen lymph nodes under armpit of injection site and dull headache was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486198
Sex: F
Age:
State: FL

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Awful; Growing pain in left ear; Excessive pressure in ear; Excessive pressure behind eye (particularly left eye); Little eye pain; Dry eyes; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:15 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, nerve damage from child birth, C-section, reactive hypoglycemia, gluten intolerance and migraine with aura. The patient had allergy to pineapple, some adhesives and some more (unspecified). The patient received other unspecified medication within two weeks of vaccination. The patient previously took rofecoxib (VIOXX), phenazopyridine hydrochloride (PYRIDIUM), diphenhydramine hydrochloride (BENADRYL) all on an unknown date for unknown indication and experienced drug allergy. The patient previously took influenza vaccine (flu shot) (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced allergy to vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 20:00, the patient experienced growing pain in left ear, excessive pressure in ear and also behind the eye particularly the left eye. The patient felt like there was expanding cotton or something in left ear which was trying to burst forth from head. At the same time, the patient also experienced dry eyes and little eye pain. It got steadily worsened all day until around 13:30 on 01Apr2021, the pain and other symptoms were just blossomed (as reported). The patient felt like the ear drum would explode or something and felt awful. The events resulted in doctor or other healthcare professional office/clinic visit. The doctor had advised the patient to report the events. The patient was advised to take ibuprofen (ADVIL) and loratadine; pseudoephedrine sulfate (CLARITIN D) for the events and to wait. The clinical outcome of the events little eye pain, dry eyes, awful, growing pain in left ear, excessive pressure in ear and excessive pressure behind eye (particularly left eye) were not recovered at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486199
Sex: F
Age:
State: AZ

Vax Date: 03/25/2021
Onset Date: 03/29/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210331; Test Name: Body temperature; Result Unstructured Data: Test Result:rose one degree

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Dull headache; Exhaustion; very bad nausea; vomiting 6x over the course of next 12 hours; Chills; 2 hives on legs; hot sweating flashes; Temperature rose one degree; Lost 5 hours sleep; Could not eat or drink; headache; Stuffy nose; shallow breathing; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8732) via an unspecified route of administration in the right arm on 25Mar2021 at 10:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included radiofrequency ablation performed on lumbar on 4 levels on 18Feb2021 for spine injury sustained post motor vehicle accident (MVA) on 20Dec2019. Concomitant medications included cortisone (MANUFACTURER UNKNOWN) and pregabalin (PREGABA) for unknown indications from unknown dates. The patient previously received pregabalin (MANUFACTURER UNKNOWN), meloxicam (MANUFACTURER UNKNOWN), paracetamol (TYLENOL), multivitamin (MANUFACTURER UNKNOWN), lysine (MANUFACTURER UNKNOWN), collagen (MANUFACTURER UNKNOWN), turmeric, fish oil (MANUFACTURER UNKNOWN), glucosamine (MANUFACTURER UNKNOWN) and norethisterone (HEATHER) for birth control. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 05:30, the patient experienced stuffy nose, headache and shallow breathing. On 30Mar2021, all the symptoms were more pronounced. On 31Mar2021, the patient had most severe day. The patient experienced painful headache very severely limiting function, shallower breathing and very bad nausea began at 12:00 followed by vomiting 6 times over the course of next 12 hours. The patient could not eat or drink. Temperature rose one degree in the evening and the patient had chills and hot sweating flashes with mostly chills. Nausea continued into the night and the patient lost 5 hours of sleep. The patient had 2 hives on the legs. The patient almost went to emergency room (ER). The patient could drink around 00:00. The headache was subsided around 02:00. The patient could eat around 03:00. On 01Apr2021, nausea reduced greatly but still was uncomfortable. Breathing was improved with no more chills or hot flashes. The patient also experienced dull headache and exhaustion. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient iced her head with compress for headache and the patient did not receive any treatment for the events stuffy nose, shallow breathing, very bad nausea, vomiting 6x over the course of next 12 hours, could not eat or drink, temperature rose one degree, chills, hot sweating flashes, lost 5 hours of sleep, 2 hives on the legs, dull headache and exhaustion. The clinical outcomes of the events chills and hot sweating flashes were resolved on 01Apr2021 while that of the headache, stuffy nose, shallow breathing, very bad nausea, vomiting 6x over the course of next 12 hours, could not eat or drink, temperature rose one degree, lost 5 hours of sleep, 2 hives on the legs, dull headache and exhaustion were resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: CORTISONE; PREGABA

Current Illness:

ID: 1486200
Sex: F
Age:
State:

Vax Date: 03/24/2021
Onset Date: 03/26/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 16:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism from an unknown date. Patient had allergies to medications, food, or other products which were unspecified. Concomitant medications included levothyroxine sodium (SYNTHROID) and vit b complex (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021, after 2 days of vaccination, the patient experienced slight itching and rash on left arm, tummy and back of torso. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events itching and rash was resolving at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: SYNTHROID; VIT B COMPLEX

Current Illness:

ID: 1486201
Sex: F
Age:
State: IL

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Didnt hurt much; This is a spontaneous report from a contactable consumer, the parent. A 17-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734) via an unspecified route of administration in the arm left on 01Apr2021 at 03:45 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 03:45, after the vaccination, the patient was feeling fine and it was easy and fast and didn't hurt much (pain). The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken as the result of adverse event. The clinical outcome of the event didn't hurt much (pain) was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486202
Sex: F
Age:
State: ME

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Sinus headache; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 30Mar2021 at 16:45 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. The patient medical history included sinus headache (happens less than two times a year). The patient had known allergies which include penicillin allergy and common seasonal and household allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 09Mar2021 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 15:00, the patient experienced sinus headache just under 24 hours 1 day after vaccination. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were taken as a result of sinus headache and included treatment with regular strength tylenol. The clinical outcome of the event sinus headache was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486203
Sex: F
Age:
State: NE

Vax Date: 03/08/2021
Onset Date: 03/09/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Metallic taste in mouth; Tinnitus; Sore armpit; Sore arm; Fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN), via an unspecified route of administration in the right arm on 08Mar2021 at 16:45 (at the age of 62-year-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN), via an unspecified route of administration in the right arm on 29Mar2021 at 19:15 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included functional natural killer cell deficiency, ulcerative colitis, lichen sclerosus, asthma, eczema, blepharitis. The patient had a history of allergies to sulfa and cephalosporins. Concomitant medications included mesalazine (LIALDA), famciclovir (FAMVIR), docusate sodium (COLACE), vitamin d not otherwise specified (NOS) (MANUFRATURER UNKNOWN), zinc (MANUFRATURER UNKNOWN), unknown active substance (COQ10) and "mi" all since an unknown date for an unknown indication. The patient previously took levofloxacin (LEVAQUIN) on an unknown date for unknown indication and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 09Mar2021 at 15:00, the patient experienced tinnitus, sore arm, sore armpit, metallic taste in mouth, fatigue and headache. The adverse events resulted in a visit to the doctors or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events tinnitus, sore arm, sore armpit, metallic taste in mouth, fatigue and headache were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LIALDA; Famvir; COLACE; VITAMIN D NOS; ZINC

Current Illness:

ID: 1486204
Sex: M
Age:
State: OH

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: 12 narrow broken blood vessels under my breasts; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Medical history included stage 4 metastatic bone cancer and patient was undergoing treatment. The patient was allergic to penicillin. Concomitant medications included apalutamide (ERLEADA) for unspecified indication. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205), via an unspecified route of administration in the left arm on 10Mar2021 at 14:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 12:00, the patient experienced 12 narrow broken blood vessels under breasts. The patient did not receive any treatment for the event. The clinical outcome of the event narrow broken blood vessels under breasts was unknown at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: ERLEADA

Current Illness:

ID: 1486205
Sex: F
Age:
State: CA

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Headache for 15 hours now.; Some nausea.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 30Mar2021 at 13:30(at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccination four weeks prior to the COVID-19 vaccination. The patient had no known allergies. On 31Mar2021 at 10:00, the patient experienced headache and vomiting. It was reported that the patient was experiencing headache since 15 hours. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache and vomiting was resolving at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486206
Sex: M
Age:
State: CA

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Dizzy; labored breathing; headache; body aches; soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 65-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6955) via an unspecified route of administration in the left arm on 26Mar2021 at 17:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not have any allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 05Mar2021 at 17:45 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 17:00, the patient experienced dizzy, labored breathing, headache, body aches, and soreness at injection site. and it was felt like he had hit by a truck within seconds and most symptoms had passed in intensity during 15 minutes waiting period. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events dizzy, labored breathing, headache, body aches and vaccination site pain were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486207
Sex: M
Age:
State: FL

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Metallic taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration on 31Mar2021 at 09:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 12:00, the patient experienced metallic taste in mouth. The patient did not receive any treatment for the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event metallic taste was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486208
Sex: M
Age:
State: NJ

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Rash near the site of the shot; Swollen neck; Swollen neck that led to pain when moving; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old male patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6204), via an unspecified route of administration in the right arm on 31Mar2021 at 13:30 (at the age of 18-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to amoxicillin. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 31Mar2021, the patient experienced rash near the site of the shot, swollen neck that led to pain when moving and swallowing, chills and fever for the first night. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as the result of rash, swollen neck, neck pain, chills and fever. The clinical outcome of the events rash near the site of the shot, swollen neck, neck pain, chills and fever were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1486209
Sex: M
Age:
State: TN

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Nose bleed a few hours after injection; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 01Apr2021 at 08:30(at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient has no allergies to medications, food, or other products. Concomitant medications included duloxetine hydrochloride (CYMBALTA), gabapentin (MANUFACTURER UNKNOWN) and lisdexamfetamine mesylate (VYVANSE) all since an unknown date taken for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 16:30 a few hours after injection the patient experienced nose bleed. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event nose bleed was recovered on 01Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: CYMBALTA; GABAPENTIN; VYVANSE

Current Illness:

ID: 1486210
Sex: F
Age:
State: GA

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Tingling/ Slight tingling on skin all over; slight numbness on face; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8737) via an unspecified route of administration in the left arm on 01Apr2021 at 16:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to aspirin (MANUFCATURER UNKNOWN). Concomitant medication included omega-3 (MANUFCATURER UNKNOWN) for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. On 01Apr2021 at 16:45, the patient experienced tingling and slight numbness on face. The patient had slight tingling on skin all over. The patient did not receive any treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of slight tingling on skin all over and numbness in face was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Omega 3

Current Illness:

ID: 1486211
Sex: F
Age:
State: IL

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Headaches; hot flashes; dry eyes; burning sending under skin on location where received fillers smile lines, cheeks; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 09:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any concomitant medication within two weeks of vaccination. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 10:15, the patient experienced headaches, hot flashes, dry eyes, burning sending under skin on location where received fillers smile lines, cheeks. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headaches, hot flashes, dry eyes and burning sensation was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1486212
Sex: F
Age:
State: OH

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: tingly (tightness) ) on right face cheek area, forehead (right side), down cheek to the right side of upper and lower lips and felt it toward right ear. Everything was on right side of face; This is a spontaneous report from a contactable consumer. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 01Apr2021 at 14:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included alpha1 carrier and migraine. It was unsure if the patient had any allergies. Concomitant medications included sumatriptan succinate (SUMATRIPTAN) indicated for migraines, multi vitamin and other unspecified medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 (also reported 02:45), the patient experienced tingly (tightness) on right face cheek area, then it went to forehead (right side), then it went down her cheek to the right side of her upper and lower lips and she also felt it towards her right ear. Everything was on the right side of face, almost exactly separated at the very center of the face. Therapeutic measure was taken as a result of event tingly and included treatment with benedryl. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tingling was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SUMATRIPTAN

Current Illness: Migraine (sumatriptan (migraines))

ID: 1486213
Sex: F
Age:
State: CA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: chills; Severe; Soreness at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 30Mar2021 at 09:00 (at the age of 43-years) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Concomitant medications included ethinylestradiol, etonogestrel (NUVARING) taken from unknown date and for unknown indication. The patient had no allergies to medications, food, or other products. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the right arm on 11Mar2021 at 09:00 (at the age of 43-years). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient experienced soreness at the injection site and on 31Mar2021, at 02:00 the patient experienced chills and severe fatigue. The patient did not receive any treatment for the events. The clinical outcome of the events soreness at the injection site, chills and fatigue was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: NUVARING

Current Illness:

ID: 1486214
Sex: M
Age:
State: NY

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 07/20/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Fatigue; Flu-like symptoms; This is a spontaneous report from a contactable physician, the patient. A 46-year-old-male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 31Mar2021 at 14:30 (at the age of 46-years-old), as a single dose for COVID -19 immunisation. Medical history included hypocholesteremia. The patient was unknown about the allergies to medications, food, or other products. Concomitant medication included atorvastatin calcium (LIPITOR) of 10mg and clomiphene (MANUFACTURER UNKNOWN) of 50mg; both for unknown indications from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247), via an unspecified route of administration in the left arm on 10Mar2021 at 14:30 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 00:00, the patient experienced fatigue and flu-like symptoms. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measure was taken as a result of fatigue and flu-like symptoms and included treatment with ADVIL of 400mg. The clinical outcomes of the events fatigue and flu-like symptoms were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LIPITOR; Clomiphene

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am